by Acute ischemic stroke (AIS) occurs due to lack of blood flow to an area of the brain, which can cause permanent damage or even death without immediate treatment. The mainstay of acute ischemic stroke treatment involves the administration of thrombolytic drugs to dissolve blood clots that cause strokes or the use of endovascular thrombectomy procedures to physically remove clots. These treatment options aim to restore blood flow and minimize brain injury if administered within the first few hours of symptom onset. The continuous development of new-generation minimally invasive devices for thrombectomy procedures and the increasing adoption of telestroke programs to expand stroke care access to rural areas are fueling market growth.
The global Acute Ischemic Stroke (AIS) Market is estimated to be valued at US$ 9211.99 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the AIS Market is the increasing adoption of thrombectomy devices. Thrombectomy devices are used to physically remove blood clots from blocked arteries and restore blood flow to the brain. Advances in thrombectomy devices allow for minimally invasive procedures that can be performed via small incisions or through arteries in the wrist or groin. Newer generation devices offer technological improvements like adjustable stent retrievers, flow diverters, and aspiration catheters that allow clinicians to treat difficult clot compositions and locations. For example, the SOLITAIRE FR thrombectomy device from Johnson and Johnson uses a self-expanding retrievable stent to capture and remove clots. Growing evidence of the benefits of mechanical thrombectomy over standard IV tPA therapy alone has driven rapid uptake of thrombectomy devices globally. This is expected to remain a major growth driver for the AIS market over the forecast period.
Porter’s Analysis
Threat of new entrants: The Global Acute Ischemic Stroke Market Size Size has moderate threat of new entrants due to the high capital investment required for R&D of new drugs and devices.
Bargaining power of buyers: The bargaining power of buyers is moderate as the treatment options for AIS are limited and buyers need services urgently.
Bargaining power of suppliers: Suppliers have low to moderate bargaining power due to the presence of many device and drug manufacturers in the market.
Threat of new substitutes: There is low threat from substitutes as acute ischemic stroke has limited treatment alternatives.
Competitive rivalry: The market witnesses high competitive rivalry due to presence of many global and regional players offering similar treatment solutions.
Key Takeaways
The global acute ischemic stroke market is expected to witness high growth over the forecast period owing to the rising geriatric population and increasing prevalence of stroke. The global Acute Ischemic Stroke (AIS) Market is estimated to be valued at US$ 9211.99 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030.
North America is projected to dominate the global market during the forecast period due to well-established healthcare facilities, availability of advanced treatment options and rising adoption rate of new technologies in the region.
Key players operating in the acute ischemic stroke market are B. Braun Melsungen AG, Baxter, BD, Johnson & Johnson Private Limited, Stryker Corp., Integra LifeSciences Corporation, Medtronic plc, Acera Surgical, Inc., Anthrex, Inc., Acelity L.P. Inc., Biorez, Aroa Biosurgery Limited, Misonix, Inc., Ortho Regenerative Technologies Inc., AlloSource, Boston Scientific Corporation, TEIJIN LIMITED, and Smith+Nephew, CONMED Corporation.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
